close_game
close_game
[

serum institute of india

]

Latest from serum institute of india

SII to develop Mpox vaccine within a year

Serum Institute of India (SII) Pune on Tuesday said it is currently working to develop a vaccine for Mpox with positive outcomes expected in a year’s time

Serum Institute of India (SII) Pune on Tuesday said it is currently working to develop a vaccine for Mpox with positive outcomes expected in a year’s time. (REUTERS (PIC FOR REPRESENTATION))
Updated on Aug 21, 2024 08:00 AM IST
ByVicky Pathare

Pune’s Serum Institute ships malaria vaccine to African countries

Serum Institute of India ships R21/Matrix-M™ malaria vaccine to Africa, starting with Central African Republic. 163,800 doses allocated for CAR.

CEO of Serum Institute of India, Adar Poonawalla and Ambassador of the United States of America to India, Eric Garcetti flag off the first consignment of R21-Matrix-M Malaria vaccine doses to Africa, in Pune on Monday. (Eric Garcetti X/ANI)
Updated on May 21, 2024 07:36 AM IST
ByVicky Pathare

SII to acquire 20% stake in needle-free tech firm IntegriMedical

Vaccine major SII on Friday announced to acquire 20 per cent stake in medical device company IntegriMedical to advance in needle-free injection system technology

Vaccine major SII on Friday announced to acquire 20 per cent stake in medical device company IntegriMedical to advance in needle-free injection system technology. ((PIC FOR REPRESENTATION))
Updated on May 18, 2024 08:18 AM IST

All Covishield side-effects were disclosed: Serum Institute of India

Emphasizing safety as a priority, the company also highlighted Covishield’s role in saving millions of lives globally.

The pharma giant has begun the worldwide withdrawal of its Covid-19 vaccine due to a ‘surplus of available updated vaccines’ that target new variants of the virus. (FILE PHOTO)
Updated on May 09, 2024 04:10 AM IST
ByVicky Pathare

Parents sue Serum Institute over daughter's death, allegedly due to Covishield

Covishield is the Indian variant of AstraZeneca's Covid-19 vaccine. AstraZeneca recently admitted that its vaccine can cause a rare side-effect called ‘TTS.’

AstraZeneca has said that due to the same vaccine, blood clotting takes place and it can lead to a lowered platelete count. (Reuters/File)
Published on May 02, 2024 11:19 AM IST
By, New Delhi
Story Saved
Live Score
Saved Articles
Following
My Reads
Sign out
New Delhi 0C
Wednesday, September 25, 2024
Start 14 Days Free Trial Subscribe Now
Follow Us On